Promising Alzheimer’s drug results hailed as ‘major milestone’
By
Kimberly Bonvissuto
Sep 29, 2022
An investigational drug showing promise in reducing cognitive decline in early Alzheimer’s disease is being hailed as having potential to “change the course” of the disease.
New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Seizures in young stroke survivors double dementia risk
Jul 29, 2022
The findings were seen for all strokes, ischemic strokes and hemorrhagic strokes.
Research focuses on diagnosing, lessening effects of Alzheimer’s disease
By
Kimberly Bonvissuto
Jun 28, 2022
More than 6 million Americans are living with Alzheimer’s disease, costing the nation $321 billion in 2022, according to the Alzheimer’s Association. A variety of studies and pilot programs are underway...
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Do you really want to know you have Alzheimer’s?
By
John O'Connor
May 05, 2022
Would you want to know if Alzheimer’s disease is starting to feast on your brain? It turns out the answer soon might be in your hands.
Smartphones: ‘digital dementia’ contributor or cognitive memory aid?
By
Kimberly Bonvissuto
May 04, 2022
Smartphones: friend or foe? It depends on whom you ask. Recent studies on smartphone use have found that mobile technology either can contribute to cognitive impairment or help improve cognition.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Artificial intelligence, MRI combination achieves 94% accuracy in predicting dementia
By
Kimberly Bonvissuto
Dec 09, 2021
A form of artificial intelligence combined with MRI scans of the brain predicted with 94% accuracy whether individuals with a specific type of early memory loss would go on to develop Alzheimer’s diseases...
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.